# Azora Therapeutics, Inc. (DE): Form 8-K, filed May 7, 2025

- Company: [Azora Therapeutics, Inc. (DE)](/companies/adil.md) (CIK 1513525)
- Form: 8-K
- Filed: 2025-05-07
- Accepted by EDGAR: May 7, 2025, 17:18 ET
- Period: 2025-05-02
- Accession: 0001213900-25-040724
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1513525/000121390025040724/ea0241155-8k_adial.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1513525/000121390025040724/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1513525/000121390025040724/ea0241155-8k_adial.htm

Filed May 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-040724. Last ingested by Listed: Nov 10, 2026, 17:05 ET. No prices; not investment advice.